Ikapharmindo Putramas Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp128 (market cap 170.67B, 665.7K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is the larger of the two by market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (665.7K versus 13.7K). Which is the better fit depends on your goals.
| IKPM | ZYRX | |
|---|---|---|
Market Cap | 304.92B | 170.67B |
Volume | 13.7K | 665.7K |
Lot | 137 | 6.66K |
Turnover | 2.49M | 84.96M |
Average Price | 181.39 | 127.62 |
Value | 2.49M | 84.96M |
Indicative Equilibrium Price | — | 130 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →